Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE studyinfo:eu-repo/semantics/OpenAccess ;ISSN: 1462-8902 ;EISSN: 1463-1326Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
Applicability of Blood Pressure-Lowering Drug Trials to Real-World Patients With Cardiovascular Diseaseinfo:eu-repo/semantics/OpenAccess ;ISSN: 0194-911X ;EISSN: 1524-4563Full text available |
| 3 |
Material Type: Article
|
|
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION studyinfo:eu-repo/semantics/OpenAccess ;ISSN: 0012-186X ;EISSN: 1432-0428Full text available |
| 4 |
Material Type: Article
|
|
Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular riskinfo:eu-repo/semantics/OpenAccess ;ISSN: 1056-8727 ;EISSN: 1873-460XFull text available |
| 5 |
Material Type: Article
|
|
External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular diseaseinfo:eu-repo/semantics/OpenAccess ;ISSN: 1475-2840 ;EISSN: 1475-2840Full text available |
| 6 |
Material Type: Article
|
|
The association of serum uric acid level with metabolic risk factors in patients with type 2 diabetes and their relation to eGFR statusThe Egyptian journal of internal medicine, 2024-12, Vol.36 (1), p.52 [Peer Reviewed Journal]The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1110-7782 ;EISSN: 2090-9098 ;DOI: 10.1186/s43162-024-00319-3Full text available |
| 7 |
Material Type: Article
|
|
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyinfo:eu-repo/semantics/OpenAccess ;ISSN: 2666-7762 ;EISSN: 2666-7762Full text available |
| 8 |
Material Type: Article
|
|
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical DataRheumatology and therapy., 2024-06, Vol.11 (3), p.487-499 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2198-6576 ;EISSN: 2198-6584 ;DOI: 10.1007/s40744-024-00662-5 ;PMID: 38696034Full text available |
| 9 |
Material Type: Article
|
|
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI studyinfo:eu-repo/semantics/OpenAccess ;ISSN: 2667-0909Digital Resources/Online E-Resources |
| 10 |
Material Type: Article
|
|
Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk: What do patients want to know?info:eu-repo/semantics/OpenAccessDigital Resources/Online E-Resources |
| 11 |
Material Type: Newsletter Article
|
|
Journal of General Internal Medicine Issues Research Articles in Vol. 39, Issue 5Targeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
| 12 |
Material Type: Newsletter Article
|
|
Bond University: Pass the Potassium and Shake Up Your HealthTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
| 13 |
Material Type: Newsletter Article
|
|
Press Release: Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 30, 2024Digital Resources/Online E-Resources |
| 14 |
Material Type: Newsletter Article
|
|
Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024PR Newswire, 2024Copyright PR Newswire Association LLC Apr 30, 2024Digital Resources/Online E-Resources |
| 15 |
Material Type: Newsletter Article
|
|
LifeMD Appoints Dr. Calum MacRae to its Board of DirectorsNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
| 16 |
Material Type: Newsletter Article
|
|
Press Release: LifeMD Appoints Dr. Calum MacRae to its Board of DirectorsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 29, 2024Digital Resources/Online E-Resources |
| 17 |
Material Type: Newsletter Article
|
|
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual MeetingNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
| 18 |
Material Type: Newsletter Article
|
|
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update: Company to host conference call at 4:30 PM EDT today, Thursday, May 9, 2024NASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
| 19 |
Material Type: Newsletter Article
|
|
Press Release: Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 9, 2024Digital Resources/Online E-Resources |
| 20 |
Material Type: Newsletter Article
|
|
Press Release: Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 6, 2024Digital Resources/Online E-Resources |
Results 1 - 20 of 30 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2018 (1)
- 2018 To 2020 (1)
- 2021 To 2021 (6)
- 2022 To 2023 (6)
- After 2023 (17)
-
More options
New Records
Resource Type
- Articles (16)
- Newsletter Articles (11)
- Newspaper Articles (3)
-
More options
Subject
- Cardiovascular Disease (27)
- Medicine (10)
- Endocrinology, Diabetes And Metabolism (7)
- Risk Factors (6)
- Humans (6)
- Product Development (5)
- Electronic Cigarettes (5)
- Tobacco (5)
- Addictions (5)
- Vaping (5)
- Regulatory Approval (5)
- Clinical Trials (5)
- Type 2 Diabetes (5)
- Mortality (5)
- Fda Approval (5)
- Smoking Cessation (5)
- Nicotine (5)
- Life Sciences (5)
- Annual Reports (4)
-
More options
Databases
- ProQuest Central (21)
- Utrecht University Repository (13)
- ROAD: Directory of Open Access Scholarly Resources (4)
- Springer Nature OA/Free Journals (4)
- DOAJ Directory of Open Access Journals (4)
- PubMed Central (3)
- GFMER Free Medical Journals (3)
- HighWire Press (Free Journals) (2)
- MEDLINE (1)
-
More options
Journal Title
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||